Coherus BioSciences, Inc. (CHRS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.1200 |
| Open | 2.1100 |
| Bid | 2.0200 x 300 |
| Ask | 2.0900 x 600 |
| Day's range | 2.0419 - 2.1250 |
| 52-week range | 1.4300 - 5.6300 |
| Volume | |
| Avg. volume | 2,264,233 |
| Market cap | 238.63M |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.7400 |
| Earnings date | 31 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.43 |
Simply Wall St.Coherus BioSciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Coherus BioSciences ( NASDAQ:CHRS ) First Quarter 2024 Results Key Financial Results Revenue: US$77.1m (up 138% from 1Q...
Insider MonkeyCoherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript
Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript May 10, 2024. CHRS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to Coherus […]
ZacksCoherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates
Coherus BioSciences (CHRS) delivered earnings and revenue surprises of -540% and 24.45%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.